Annovis Bio, Inc. (ANVS) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth 12.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | 12.5% |
| EPS Growth (YoY) | -61.9% |
| Price / Sales | 246.74 |
| Sector P/E (Healthcare) | 21.7 |
ANVS overview · ANVS earnings · ANVS KPIs · ANVS investor relations · ANVS ownership · ANVS peers · ANVS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.